Q2 2015 13F Holders as of 6/30/2015
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
237M
-
Number of holders
-
22
-
Total 13F shares, excl. options
-
3.42M
-
Shares change
-
+79.6K
-
Total reported value, excl. options
-
$31.7M
-
Value change
-
+$721K
-
Number of buys
-
13
-
Number of sells
-
-5
-
Price
-
$9.26
Significant Holders of ADMA BIOLOGICS, INC. - COMMON STOCK (ADMA) as of Q2 2015
23 filings reported holding ADMA - ADMA BIOLOGICS, INC. - COMMON STOCK as of Q2 2015.
ADMA BIOLOGICS, INC. - COMMON STOCK (ADMA) has 22 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 3.42M shares
of 237M outstanding shares and own 1.44% of the company stock.
Largest 10 shareholders include Consonance Capital Management LP (1.03M shares), Broadfin Capital, LLC (964K shares), FMR LLC (423K shares), FRANKLIN RESOURCES INC (357K shares), PointState Capital LP (203K shares), J. Goldman & Co LP (123K shares), Weiss Multi-Strategy Advisers LLC (90K shares), Telemetry Investments, L.L.C. (80.9K shares), Alyeska Investment Group, L.P. (50.8K shares), and UBS OCONNOR LLC (36.4K shares).
This table shows the top 22 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.